Generic Name and Formulations:
Ciclesonide 50mcg/spray; aqueous nasal spray.
Indications for OMNARIS:
Treatment of seasonal allergic rhinitis in patients ≥6yrs old and perennial allergic rhinitis in patients ≥12yrs old.
2 sprays in each nostril once daily (200mcg/day).
Seasonal allergic rhinitis: <6yrs: not recommended. ≥6yrs: 2 sprays in each nostril once daily (200mcg/day).
Avoid use in patients with recent nasal ulcers/surgery/trauma until healed. Potential worsening of active tuberculosis; fungal, bacterial, viral, or parasitic infections, or ocular herpes simplex. If exposed to measles or chickenpox, consider immunoglobulin prophylactic therapy. If adrenal suppression exists following systemic corticosteroid therapy, replacement with topical steroids may exacerbate symptoms of adrenal insufficiency. Monitor for hypercorticism and HPA axis suppression (if occur discontinue slowly), and for candida infection and other nasal mucosal changes. Monitor for vision changes or with history of increased intraocular pressure, glaucoma and/or cataracts. Monitor for growth suppression in children. Avoid spraying eyes, or directly onto the nasal septum. Reevaluate if no improvement after 2 weeks (for seasonal allergic rhinitis) and 5 weeks (for perennial allergic rhinitis). Pregnancy (Cat. C). Nursing mothers.
May be potentiated by ketoconazole.
Headache, epistaxis, nasopharyngitis, ear pain, pharyngolaryngeal pain.
Nasal spray (pump)—12.5g (120 sprays)
Endocrinology Advisor Articles
- Testosterone Use Remains High Among Men With Coronary Artery Disease
- Higher Risk for Venous Thromboembolism With Oral vs Transdermal HRT
- Comparing Osteoporosis Screening, Treatment Strategies in Postmenopausal Women
- Primary Characteristics of PCOS Predictive of Obstetric Complications
- Free vs Total Serum 25(OH)D as Biomarkers for Bone Health in Older Women
- ADA's 2019 Standards of Medical Care in Diabetes Focus on Patient-Centered Care
- Sleep Habits Affect Insulin Sensitivity in Adolescents With Overweight, Obesity
- Levothyroxine Associated With Increased Mortality in Patients With Heart Failure
- Head-to-Head Comparison of Professional vs Personal CGM Systems in T1D
- Dual vs Triple Therapy for Metformin Treatment Intensification in Type 2 Diabetes
- Insulin Analogs vs Regular Human Insulin for Type 2 Diabetes
- Diabetic Ketoacidosis May Affect Brain Development in Children With T1D
- Higher Rates of Comorbidities Among Holocaust Survivors
- Population Health Data May Help Identify Patients at Risk for CVD
- Newborn Genomic Sequencing Can Identify Disease Risk